Research article summary (published 30 Dec 1992):

Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Rascol, O J (OJ); Sabatini, U (U); Chollet, F (F); Montastruc, J L (JL); Marc-Vergnes, J P (JP); Rascol, A (A);

Affiliation: Laboratoire de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine, Toulouse, France.

Journal and publication information

Publication Type: Journal Article

Journal: Advances in neurology (Adv Neurol), published in UNITED STATES. (Language: eng)

Reference: 1993-; vol 60 (issue ) : pp 419-21

Dates: Created 1993/02/11; Completed 1993/02/11; Revised 2004/11/17;

PMID: 8420165, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Aged Apomorphine - therapeutic use Brain - blood supply Dopamine - physiology Female Humans Injections, Subcutaneous Levodopa - therapeutic use Male Middle Aged

Middle Aged Motor Activity - drug effects; physiology Motor Cortex - drug effects; physiopathology Movement Disorders - drug therapy; physiopathology Muscle Rigidity - drug therapy; physiopathology Neurologic Examination - drug effects Parkinson Disease - drug therapy; physiopathology Regional Blood Flow - drug effects; physiology Somatosensory Cortex - drug effects; physiopathology Tomography, Emission-Computed, Single-Photon

Associated Chemicals: Levodopa (0) ; Dopamine (51-61-6) ; Apomorphine (58-00-4)

Related articles

These are the highest related articles currently in the database:

• Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease. 29 Jun 1993
• Spatiotemporal study of event-related desynchronization in idiopathic Parkinson's disease. 30 Dec 1992
• [Sublingual administration of apomorphine in the treatment of motor fluctuations in Parkinson disease] 30 Dec 1991
• Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease. 30 Oct 1992
• Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. 29 Nov 1992
• Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon. 30 May 1996
• Parkinson's disease and lower limb somatosensory evoked potentials: apomorphine-induced relief of the akinetic-rigid syndrome and vertex P37-N50 potentials. 30 Mar 1999
• Extradural motor cortex stimulation (EMCS) for Parkinson's disease. History and first results by the study group of the Italian neurosurgical society. 30 Dec 2004
• Brain implants in man do not break down the blood-brain barrier to dopamine and domperidone. 2 Sep 1992

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.